In addition to samples from CRC patients, samples from the precursor adenomatous polyp-bearing patients (patients’ information in S9) had a lower expression of ITGAM as well, which collectively suggested that ITGAM-positive exosomes could be utilized as biomarkers for early diagnosis of CRC (Fig. 3C). This evidence concerns the gene ITGAM and colorectal carcinoma.